Blood-brain barrier permeability and tPA-mediated neurotoxicity.
Fanne RA, Nassar T, Yarovoi S, Rayan A, Lamensdorf I, Karakoveski M, Vadim P, Fanne RA, Jamal M, Cines DB, Al-Roof Higazi A.
Neuropharmacology. 2010 Jan 7. [Epub ahead of print] PMID: 20060006
Spontaneous aortitis in the Balb/c mouse.
Ramot Y, Manno RA, Okazaki Y, Krakovsky M, Lamensdorf I, Meiron M, Toren A, Zehavi-Goldstein E, Vezzali E, Nyska A.
Toxicol Pathol. 2009;37(5):667-71. Epub 2009 May 27.PMID: 19474416
Development of drugs for CNS disorders – the Blood Brain Barrier. Lamensdorf I. Pharmaline 20, February 2006. 14-15/32-33.[Hebrew]
Sphenopalatine Ganglion (SPG) Stimulation in acute stroke model. Yarnitsky D, Lorian A, Dayan A, Avnon Y, Karakovsky M, Lamensdorf I. Poster in April 2006 International Stroke Conference, Orlando, FL
Blood-brain barrier opened by stimulation of the parasympathetic sphenopalatine ganglion: a new method for macromolecule delivery to the brain. Yarnitsky D, Gross Y, Lorian A, Shalev A, Lamensdorf I, Bornstein R, Shorer S, Mayevsky A, Patel KP, Abbott NJ, Mayhan WG. J Neurosurg. August 2004 ; 101(2):303-9.
Delivery of antisense-based compounds to the brain. Lamensdorf I. The 4th annual meeting of the Israeli Chapter of the Controlled Release Society, Meridian Haifa,
18 - 19 September 2003. |
